Tower Research Capital LLC (TRC) - ITERUM THERAPEUTICS PLC ownership

ITERUM THERAPEUTICS PLC's ticker is and the CUSIP is G6333L200. A total of 15 filers reported holding ITERUM THERAPEUTICS PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ITERUM THERAPEUTICS PLC
ValueSharesWeighting
Q2 2024$114
-84.2%
100
-78.6%
0.00%
Q1 2024$721
+3905.6%
468
+2027.3%
0.00%
Q3 2023$18
-47.1%
22
-31.2%
0.00%
Q2 2023$34
+240.0%
32
-99.7%
0.00%
Q1 2023$10
+150.0%
9,668
+119.7%
0.00%
Q4 2022$4
-99.8%
4,401
+232.9%
0.00%
Q3 2022$2,0001,3220.00%
Other shareholders
ITERUM THERAPEUTICS PLC shareholders Q4 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 75,000$1,125,0000.92%
New Leaf Venture Partners, L.L.C. 97,084$103,8800.09%
Apollon Wealth Management, LLC 200,000$214,0000.01%
Kelly Financial Services LLC 120$1280.00%
WELLS FARGO & COMPANY/MN 85$910.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 48$510.00%
NewEdge Advisors, LLC 100$1070.00%
OSAIC HOLDINGS, INC. 12$120.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 13,150$14,0710.00%
View complete list of ITERUM THERAPEUTICS PLC shareholders